Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia.
Publication
, Journal Article
Wilson, B; Viau, R; Perez, F; Jiang, H; Fowler, VG; Chambers, HF; Kreiswirth, BN; Bonomo, RA; Evans, SR; ARLG,
Published in: Open Forum Infect Dis
July 2019
[This corrects the article DOI: 10.1093/ofid/ofy209.142.].
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Open Forum Infect Dis
DOI
ISSN
2328-8957
Publication Date
July 2019
Volume
6
Issue
7
Start / End Page
ofz267
Location
United States
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wilson, B., Viau, R., Perez, F., Jiang, H., Fowler, V. G., Chambers, H. F., … ARLG, . (2019). Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia. Open Forum Infect Dis, 6(7), ofz267. https://doi.org/10.1093/ofid/ofz267
Wilson, Brigid, Roberto Viau, Federico Perez, Hongyu Jiang, Vance G. Fowler, Henry F. Chambers, Barry N. Kreiswirth, Robert A. Bonomo, Scott R. Evans, and Scott R. ARLG. “Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia.” Open Forum Infect Dis 6, no. 7 (July 2019): ofz267. https://doi.org/10.1093/ofid/ofz267.
Wilson B, Viau R, Perez F, Jiang H, Fowler VG, Chambers HF, et al. Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia. Open Forum Infect Dis. 2019 Jul;6(7):ofz267.
Wilson, Brigid, et al. “Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia.” Open Forum Infect Dis, vol. 6, no. 7, July 2019, p. ofz267. Pubmed, doi:10.1093/ofid/ofz267.
Wilson B, Viau R, Perez F, Jiang H, Fowler VG, Chambers HF, Kreiswirth BN, Bonomo RA, Evans SR, ARLG. Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia. Open Forum Infect Dis. 2019 Jul;6(7):ofz267.
Published In
Open Forum Infect Dis
DOI
ISSN
2328-8957
Publication Date
July 2019
Volume
6
Issue
7
Start / End Page
ofz267
Location
United States
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences